Hoseah M Akala1, Oliver J Watson2, Kenneth K Mitei3, Dennis W Juma4, Robert Verity2, Luicer A Ingasia5, Benjamin H Opot4, Raphael O Okoth4, Gladys C Chemwor4, Jackline A Juma4, Edwin W Mwakio4, Nicholas Brazeau6, Agnes C Cheruiyot4, Redemptah A Yeda4, Maureen N Maraka4, Charles O Okello4, David P Kateete3, Jim Ray Managbanag4, Ben Andagalu4, Bernhards R Ogutu4, Edwin Kamau7. 1. Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya. Electronic address: hosea.akala@usamru-k.org. 2. Medical Research Council, Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK. 3. College of Health Sciences, Makerere University, Kampala, Uganda. 4. Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya. 5. Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. 6. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA. 7. Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate-Africa, Kenya Medical Research Institute/Walter Reed Project, Kisumu, Kenya; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Abstract
BACKGROUND: The epidemiology and severity of non-falciparum malaria in endemic settings has garnered little attention. We aimed to characterise the prevalence, interaction, clinical risk factors, and temporal trends of non-falciparum Plasmodium species among symptomatic individuals presenting at health-care facilities in endemic settings of Kenya. METHODS: We diagnosed and analysed infecting malaria species (Plasmodium falciparum, Plasmodium ovale curtisi, Plasmodium ovale wallikeri, and Plasmodium malariae) via PCR in clinical samples collected between March 1, 2008, and Dec 31, 2016, from six hospitals located in different regions of Kenya. We recruited patients aged 6 months or older who presented at outpatient departments with symptoms of malaria or tested positive for uncomplicated malaria by malaria rapid diagnostic test. Descriptive statistics were used to describe the prevalence and distribution of Plasmodium species. A statistical model was designed and used for estimating the frequency of Plasmodium species and assessing interspecies interactions. Mixed-effect linear regression models with random slopes for each location were used to test for change in prevalence over time. FINDINGS: Samples from 2027 symptomatic participants presenting at care facilities were successfully analysed for all Plasmodium species. 1469 (72·5%) of the samples were P falciparum single-species infections, 523 (25·8%) were mixed infections, and only 35 (1·7%) were single non-falciparum species infections. 452 (22·3%) were mixed infections containing P ovale spp. A likelihood-based model calculation of the population frequency of each species estimated a significant within-host interference between P falciparum and P ovale curtisi. Mixed-effect logistic regression models identified a significant increase in P ovale wallikeri (2·1% per year; p=0·043) and P ovale curtisi (0·7% per year; p=0·0002) species over time, with a reciprocal decrease in P falciparum single-species infections (2·5% per year; p=0·0065). The frequency of P malariae infections did not significantly change over time. Risk of P falciparum infections presenting with fever was lower if co-infected with P malariae (adjusted odds ratio 0·43, 95% CI 0·25-0·74; p=0·0023). INTERPRETATION: Our results show a prevalence of non-falciparum species infections of 27·5% among symptomatic individuals presenting at care facilities, which is higher than expected from previous cross-sectional surveys. The proportion of infections with P ovale wallikeri and P ovale curtisi was observed to significantly increase over the period of study, which could be due to attenuated responsiveness of these species to malaria drug treatment. The increase in frequency of P ovale spp could threaten the malaria control efforts in Kenya and pose increased risk of malaria to travellers. FUNDING: Armed Forces Health Surveillance Branch and its Global Emerging Infections Surveillance Section.
BACKGROUND: The epidemiology and severity of non-falciparum malaria in endemic settings has garnered little attention. We aimed to characterise the prevalence, interaction, clinical risk factors, and temporal trends of non-falciparum Plasmodium species among symptomatic individuals presenting at health-care facilities in endemic settings of Kenya. METHODS: We diagnosed and analysed infecting malaria species (Plasmodium falciparum, Plasmodium ovale curtisi, Plasmodium ovale wallikeri, and Plasmodium malariae) via PCR in clinical samples collected between March 1, 2008, and Dec 31, 2016, from six hospitals located in different regions of Kenya. We recruited patients aged 6 months or older who presented at outpatient departments with symptoms of malaria or tested positive for uncomplicated malaria by malaria rapid diagnostic test. Descriptive statistics were used to describe the prevalence and distribution of Plasmodium species. A statistical model was designed and used for estimating the frequency of Plasmodium species and assessing interspecies interactions. Mixed-effect linear regression models with random slopes for each location were used to test for change in prevalence over time. FINDINGS: Samples from 2027 symptomatic participants presenting at care facilities were successfully analysed for all Plasmodium species. 1469 (72·5%) of the samples were P falciparum single-species infections, 523 (25·8%) were mixed infections, and only 35 (1·7%) were single non-falciparum species infections. 452 (22·3%) were mixed infections containing P ovale spp. A likelihood-based model calculation of the population frequency of each species estimated a significant within-host interference between P falciparum and P ovale curtisi. Mixed-effect logistic regression models identified a significant increase in P ovale wallikeri (2·1% per year; p=0·043) and P ovale curtisi (0·7% per year; p=0·0002) species over time, with a reciprocal decrease in P falciparum single-species infections (2·5% per year; p=0·0065). The frequency of P malariae infections did not significantly change over time. Risk of P falciparum infections presenting with fever was lower if co-infected with P malariae (adjusted odds ratio 0·43, 95% CI 0·25-0·74; p=0·0023). INTERPRETATION: Our results show a prevalence of non-falciparum species infections of 27·5% among symptomatic individuals presenting at care facilities, which is higher than expected from previous cross-sectional surveys. The proportion of infections with P ovale wallikeri and P ovale curtisi was observed to significantly increase over the period of study, which could be due to attenuated responsiveness of these species to malaria drug treatment. The increase in frequency of P ovale spp could threaten the malaria control efforts in Kenya and pose increased risk of malaria to travellers. FUNDING: Armed Forces Health Surveillance Branch and its Global Emerging Infections Surveillance Section.
Authors: Guofa Zhou; Jessica S Li; Ednah N Ototo; Harrysone E Atieli; Andrew K Githeko; Guiyun Yan Journal: Malar J Date: 2014-09-03 Impact factor: 2.979
Authors: Laura E B Nabarro; Debbie Nolder; Claire Broderick; Behzad Nadjm; Valerie Smith; Marie Blaze; Anna M Checkley; Peter L Chiodini; Colin J Sutherland; Christopher J M Whitty Journal: BMC Med Date: 2018-11-27 Impact factor: 8.775
Authors: Mirjam Groger; Luzia Veletzky; Albert Lalremruata; Chiara Cattaneo; Johannes Mischlinger; Rella Manego Zoleko; Johanna Kim; Anna Klicpera; Elias L Meyer; Daniel Blessborn; Markus Winterberg; Ayola A Adegnika; Selidji T Agnandji; Peter G Kremsner; Benjamin Mordmüller; Ghyslain Mombo-Ngoma; Hans-Peter Fuehrer; Michael Ramharter Journal: Clin Infect Dis Date: 2019-11-27 Impact factor: 9.079
Authors: Daniel A Pfeffer; Timothy C D Lucas; Daniel May; Joseph Harris; Jennifer Rozier; Katherine A Twohig; Ursula Dalrymple; Carlos A Guerra; Catherine L Moyes; Mike Thorn; Michele Nguyen; Samir Bhatt; Ewan Cameron; Daniel J Weiss; Rosalind E Howes; Katherine E Battle; Harry S Gibson; Peter W Gething Journal: Malar J Date: 2018-10-05 Impact factor: 2.979
Authors: Colleen M Leonard; Jimee Hwang; Ashenafi Assefa; Rose Zulliger; Baltazar Candrinho; Pedro Rafael Dimbu; Abuchahama Saifodine; Mateusz Plucinski; Eric Rogier Journal: Open Forum Infect Dis Date: 2022-05-18 Impact factor: 4.423
Authors: Aurel Holzschuh; Maria Gruenberg; Natalie E Hofmann; Rahel Wampfler; Benson Kiniboro; Leanne J Robinson; Ivo Mueller; Ingrid Felger; Michael T White Journal: PLoS Negl Trop Dis Date: 2022-09-13